Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) ROCE % : 0.00% (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pharmedic Pharmaceutical Medicinal Joint Stock Company's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

Pharmedic Pharmaceutical Medicinal Joint Stock Company ROCE % Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company ROCE % Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data

Trend

ROCE %

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data

ROCE %

Pharmedic Pharmaceutical Medicinal Joint Stock Company ROCE % Calculation

Pharmedic Pharmaceutical Medicinal Joint Stock Company's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Pharmedic Pharmaceutical Medicinal Joint Stock Company's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: . 20 )		(Q: . 20 )		(Q: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is four times the quarterly (. 20) EBIT data.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pharmedic Pharmaceutical Medicinal Joint Stock Company ROCE % Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM

Website

https://www.pharmedic.com.vn

Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010